ACB
Price
$4.97
Change
-$0.00 (-0.00%)
Updated
Sep 16, 12:09 PM (EDT)
Capitalization
278.06M
51 days until earnings call
SNDL
Price
$2.52
Change
+$0.02 (+0.80%)
Updated
Sep 16, 11:42 AM (EDT)
Capitalization
643.38M
62 days until earnings call
Interact to see
Advertisement

ACB vs SNDL

Header iconACB vs SNDL Comparison
Open Charts ACB vs SNDLBanner chart's image
Aurora Cannabis
Price$4.97
Change-$0.00 (-0.00%)
Volume$700
Capitalization278.06M
SNDL
Price$2.52
Change+$0.02 (+0.80%)
Volume$1.5K
Capitalization643.38M
ACB vs SNDL Comparison Chart in %
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. SNDL commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Hold and SNDL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (ACB: $4.97 vs. SNDL: $2.50)
Brand notoriety: ACB: Notable vs. SNDL: Not notable
ACB represents the Pharmaceuticals: Generic, while SNDL is part of the Beverages: Alcoholic industry
Current volume relative to the 65-day Moving Average: ACB: 46% vs. SNDL: 68%
Market capitalization -- ACB: $278.06M vs. SNDL: $643.38M
ACB [@Pharmaceuticals: Generic] is valued at $278.06M. SNDL’s [@Beverages: Alcoholic] market capitalization is $643.38M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.82B to $0. The market cap for tickers in the [@Beverages: Alcoholic] industry ranges from $19.33T to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.9B. The average market capitalization across the [@Beverages: Alcoholic] industry is $6.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileSNDL’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • SNDL’s FA Score: 0 green, 5 red.
According to our system of comparison, SNDL is a better buy in the long-term than ACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 6 TA indicator(s) are bullish while SNDL’s TA Score has 4 bullish TA indicator(s).

  • ACB’s TA Score: 6 bullish, 5 bearish.
  • SNDL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACB is a better buy in the short-term than SNDL.

Price Growth

ACB (@Pharmaceuticals: Generic) experienced а +2.69% price change this week, while SNDL (@Beverages: Alcoholic) price change was +4.60% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +27.33%. For the same industry, the average monthly price growth was +28.05%, and the average quarterly price growth was +64.12%.

The average weekly price growth across all stocks in the @Beverages: Alcoholic industry was -1.89%. For the same industry, the average monthly price growth was +3.15%, and the average quarterly price growth was -1.57%.

Reported Earning Dates

ACB is expected to report earnings on Nov 06, 2025.

SNDL is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+27.33% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Beverages: Alcoholic (-1.89% weekly)

The alcoholic beverage market includes beer, wine, and spirits. From $230 billion in 2015, the industry has grown to around $250 billion by 2019. In recent years, alcoholic beverage makers have been looking to expand distribution and purchase channels, such as through online stores (e.g. e-commerce platform Drizly) and convenience stores. Anheuser-Busch In Bev and Diageo are major global alcoholic beverage companies, while U.S.-owned companies include Constellation Brands and Brown-Forman Corp. among several others.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDL($643M) has a higher market cap than ACB($278M). SNDL YTD gains are higher at: 39.665 vs. ACB (16.941). ACB has higher annual earnings (EBITDA): 26.6M vs. SNDL (-39.96M). SNDL has more cash in the bank: 212M vs. ACB (140M). ACB has less debt than SNDL: ACB (102M) vs SNDL (151M). SNDL has higher revenues than ACB: SNDL (944M) vs ACB (358M).
ACBSNDLACB / SNDL
Capitalization278M643M43%
EBITDA26.6M-39.96M-67%
Gain YTD16.94139.66543%
P/E Ratio19.44N/A-
Revenue358M944M38%
Total Cash140M212M66%
Total Debt102M151M68%
FUNDAMENTALS RATINGS
ACB vs SNDL: Fundamental Ratings
ACB
SNDL
OUTLOOK RATING
1..100
6616
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9395
PRICE GROWTH RATING
1..100
6438
P/E GROWTH RATING
1..100
9191
SEASONALITY SCORE
1..100
9090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACB's Valuation (58) in the Pharmaceuticals Other industry is in the same range as SNDL (68) in the null industry. This means that ACB’s stock grew similarly to SNDL’s over the last 12 months.

ACB's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as SNDL (100) in the null industry. This means that ACB’s stock grew similarly to SNDL’s over the last 12 months.

ACB's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as SNDL (95) in the null industry. This means that ACB’s stock grew similarly to SNDL’s over the last 12 months.

SNDL's Price Growth Rating (38) in the null industry is in the same range as ACB (64) in the Pharmaceuticals Other industry. This means that SNDL’s stock grew similarly to ACB’s over the last 12 months.

SNDL's P/E Growth Rating (91) in the null industry is in the same range as ACB (91) in the Pharmaceuticals Other industry. This means that SNDL’s stock grew similarly to ACB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBSNDL
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 20 days ago
78%
Bullish Trend 1 day ago
74%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCLSX25.44N/A
N/A
Goldman Sachs Large Cp Val Insghts Svc
DASCX19.16N/A
N/A
Dean Small Cap Value
TRVPX18.98N/A
N/A
Nuveen Mid Cap Value Premier
ITHVX59.65N/A
N/A
Hartford Capital Appreciation R6
IPAYX11.23-0.03
-0.27%
Integrity Dividend Summit I

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been loosely correlated with SNDL. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ACB jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
+2.05%
SNDL - ACB
65%
Loosely correlated
+3.73%
CGC - ACB
64%
Loosely correlated
+1.46%
OGI - ACB
62%
Loosely correlated
+3.01%
CRON - ACB
54%
Loosely correlated
+0.79%
TLRY - ACB
54%
Loosely correlated
+5.36%
More